Digitalis Bio Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Digitalis Bio General Information
Description
Developer of artificial intelligence-based drug discovery software designed to evaluate chemical compounds and predict therapeutic outcomes. The company's platform analyzes molecular structures for efficacy and toxicity risk using computational modeling, enabling pharmaceutical companies to streamline candidate selection while reducing experimental testing effort and development cost.
Contact Information
Corporate Office
- Berkeley, CA
- United States
Corporate Office
- Berkeley, CA
- United States
Digitalis Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 05-Apr-2024 | Completed | Startup |
Digitalis Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CITRIS Foundry | Accelerator/Incubator |
Digitalis Bio FAQs
-
Where is Digitalis Bio headquartered?
Digitalis Bio is headquartered in Berkeley, CA.
-
What industry is Digitalis Bio in?
Digitalis Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Digitalis Bio a private or public company?
Digitalis Bio is a Private company.
-
What is Digitalis Bio’s current revenue?
The current revenue for Digitalis Bio is .
-
Who are Digitalis Bio’s investors?
CITRIS Foundry has invested in Digitalis Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process